Recent APS Webinars

As an APS member, you will always have access to the presentations we use during our Webinars. PDF’s from recent Webinars are available for download below.

Emerging Technologies

From 20th January 2022.

Machine Learning and AI for Drug Design

Cell to Gene Therapy – May 2021

From 12th May 2021.

Development of gene-based nanomedicines for cancer therapy-CHRISTINE DUFES.

From 12th May 2021.

Formulation considerations for T-cell therapies-CHRIS VAN DER WALLE

From 19th May 2021.

Manufacturing for Advanced Therapy Medicinal Products -Julie Kerby

From 26th May 2021.

In vivo gene therapy: CMC Development and Regulatory Challenges -Joanne Broadhead

From 26th May 2021.

Clinical Application & Trial Process -Alice Mason

Crossing Biological Barriers with Nanomedicines- April to November 2021

From 29th April 2021.

Phenotypic nanomedicines: integrating personalised medicine into drug delivery -Prof Giuseppe Battaglia

From 24th June 2021.

Nanomedicines to enable innovative medicines – Marianne Ashford

From 29th July 2021.

taking a nanoparticle medical product into the global market

Developing Clinically Relevant Dissolution Specifications (CRDS) for Oral Drug products

From 19th January 2021.

Why, What, How and When?”
View Discussion-Questions and Answers

From 2nd March 2021.

Introduction to PBPK/PBBM. The How and the Why.
View Discussion-Questions and Answers

From 20th April 2021.

How to develop CRDS including case studies from Industry
View Discussion-Questions and Answers

From 18th May 2021.

Overview of global regulatory trends within CRDS including progress, challenges and emerging opportunities
View Discussion-Questions and Answers

From 18th May 2021.

Overview of global regulatory trends within CRDS including progress, challenges and emerging opportunities
View Discussion-Questions and Answers

From 15th June 2021.

How to Use Modeling and Simulation to Link In Vitro Dissolution to Drugs’ In Vivo Behavior
View Discussion-Questions and Answers

From 15th June 2021.

Future developments with PBBM/PBPK software packages

From 29th June 2021.

An in vitro-in silico approach to predicting oral absorption of drugs when co-administered with Proton pump inhibitors

From 29th June 2021.

Predicting preclinical outcomes – an in vitro-in silico approach to guide oral formulation design

From 29th June 2021.

Absorption modelling: a brief history, emerging trends and path forward

Virtual Webinar Autumn 2020 – Age Related Medicines Focus Group

From September 30th 2020.

View Ageing Microbiome Presentation

From September 30th 2020.

View Microbiome Drug Interactions Presentations

From October 21st 2020.

View Ageing Gut-Biopharmaceutical Consideration

From October 21st 2020.

View Mind the Gap, oral medicines for older people

From November 5th 2020.

Including the Elderly in Clinical Trials

From November 19th 2020.

View Challenges in Low and Middle Income Countries

From November 19th 2020.

View Challenges in Low and Middle Income Countries

Manufacturing Classification System: Putting numbers to tablet development.

Kendal Pitt
Senior Technical Director
Pharma Supply Chain
GSK

Webinar held on the 31st October 2020

Download Manufacturing Classification PDF